A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.
The US Food and Drug Administration signed off on the first new type of pain reliever to be approved in more than two decades ...
For the first time in 20 years, the Food and Drug Administration has approved a new pharmaceutical approach to treating pain.
Investigative Journalism Foundation on MSN3h
Alberta opioid data shows drop in deaths, overdoses—but some are dying more than othersWhile overdose rates have dropped amongst the middle-class, especially casual recreational users, the drug supply has become ...
New synthetic opioids (NSOs) are one of the fastest-growing groups of new psychoactive substances around the world ...
The Food and Drug Administration on Thursday approved Journavx, a non-opioid painkiller that is the first novel pain drug to win government authorization in more than 20 years. Vertex ...
Unlike opium, nitazenes and other synthetic opioids can be produced anywhere in the world using precursor chemicals that are often uncontrolled.
The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...
For the first time in more than 25 years, the U.S. Food and Drug Administration has signed off on a new type of pain reliever ...
A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...
A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results